• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-1274a 作为骨肉瘤患者的预后生物标志物,通过靶向 ADAM9 参与肿瘤进展。

MicroRNA-1274a serves as a prognostic biomarker in patients with osteosarcoma and is involved in tumor progression via targeting ADAM9.

机构信息

Department of Joint Orthopaedics, Weifang Traditional Chinese Hospital, Weifang, Shandong, China.

Department of Joint Surgery, Weifang People's Hospital, Weifang, Shandong, China.

出版信息

J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):151-160. doi: 10.23812/20-695-A.

DOI:10.23812/20-695-A
PMID:33543608
Abstract

Osteosarcoma (OS) is the most frequent primary malignancy in bone, and commonly occurs in children and adolescents. The aim of this study was to assess the aberrant expression of miR-1274a in OS patients, and to evaluate the role of miR-1274a as a prognostic biomarker and tumor suppressor in OS progression. miR-1274a expression was estimated using quantitative real-time polymerase chain reaction. The Kaplan-Meier method and Cox regression analysis were used to evaluate the prognostic value of miR-1274a in OS. Gain- and loss-of-function in vitro experiments were used to explore the functional role of miR-1274a in OS progression. A target gene of miR-1274a was analyzed using a dual-luciferase reporter assay. miR-1274a expression was decreased in OS tissues and associated with distant metastasis and clinical stages in OS patients. Low miR-1274a could predict poor overall survival and disease-free survival in OS. The overexpression of miR-1274a could inhibit OS cell proliferation, migration and invasion. Additionally, ADAM9 was demonstrated to serve as a direct target of miR-1274a in OS cells. In conclusion, reduced miR-1274a predicts poor prognosis and serves as a potential tumor suppressor in OS. ADAM9 is a target of miR-1274a, which may mediate the functional role of miR-1274a in OS progression.

摘要

骨肉瘤(OS)是最常见的原发性骨恶性肿瘤,常见于儿童和青少年。本研究旨在评估 miR-1274a 在 OS 患者中的异常表达,并评估 miR-1274a 作为 OS 进展的预后生物标志物和肿瘤抑制因子的作用。采用实时定量聚合酶链反应(PCR)估计 miR-1274a 的表达。采用 Kaplan-Meier 法和 Cox 回归分析评估 miR-1274a 在 OS 中的预后价值。采用体外 gain-和 loss-of-function 实验探索 miR-1274a 在 OS 进展中的功能作用。采用双荧光素酶报告基因检测分析 miR-1274a 的靶基因。miR-1274a 在 OS 组织中表达降低,与 OS 患者的远处转移和临床分期相关。低 miR-1274a 可预测 OS 患者总生存期和无病生存期不良。miR-1274a 的过表达可抑制 OS 细胞的增殖、迁移和侵袭。此外,ADAM9 被证明是 OS 细胞中 miR-1274a 的直接靶基因。总之,miR-1274a 的下调预示着预后不良,可作为 OS 中的潜在肿瘤抑制因子。ADAM9 是 miR-1274a 的靶基因,可能介导 miR-1274a 在 OS 进展中的功能作用。

相似文献

1
MicroRNA-1274a serves as a prognostic biomarker in patients with osteosarcoma and is involved in tumor progression via targeting ADAM9.微小 RNA-1274a 作为骨肉瘤患者的预后生物标志物,通过靶向 ADAM9 参与肿瘤进展。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):151-160. doi: 10.23812/20-695-A.
2
miR-541 serves as a prognostic biomarker of osteosarcoma and its regulatory effect on tumor cell proliferation, migration and invasion by targeting TGIF2.miR-541 可作为骨肉瘤的预后生物标志物,通过靶向 TGIF2 调控骨肉瘤细胞的增殖、迁移和侵袭。
Diagn Pathol. 2020 Jul 24;15(1):96. doi: 10.1186/s13000-020-01008-9.
3
MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.微小RNA-99b可预测骨肉瘤的临床结局,并抑制肿瘤细胞的增殖、迁移和侵袭。
Diagn Pathol. 2019 Oct 24;14(1):117. doi: 10.1186/s13000-019-0889-y.
4
MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.miR-455-3p 下调促进骨肉瘤细胞增殖和侵袭并预测不良预后。
J Orthop Surg Res. 2020 Oct 2;15(1):454. doi: 10.1186/s13018-020-01967-1.
5
MicroRNA‑302a suppresses cell proliferation, migration and invasion in osteosarcoma by targeting ADAM9.微小RNA-302a通过靶向解聚素金属蛋白酶9抑制骨肉瘤细胞的增殖、迁移和侵袭。
Mol Med Rep. 2017 Sep;16(3):3565-3572. doi: 10.3892/mmr.2017.6975. Epub 2017 Jul 14.
6
Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation, migration and invasion by targeting PSMC2.miR-630 表达水平降低预示着骨肉瘤预后不良,并通过靶向 PSMC2 促进细胞增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):1915-1925. doi: 10.26355/eurrev_201903_17229.
7
miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.miR-216a 通过靶向 CDK14 抑制骨肉瘤细胞的增殖、侵袭和转移。
Cell Death Dis. 2017 Oct 12;8(10):e3103. doi: 10.1038/cddis.2017.499.
8
MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.微小 RNA-185 通过靶向囊泡相关膜蛋白 2 抑制人骨肉瘤 MG63 细胞的增殖、迁移和侵袭。
Gene. 2019 May 15;696:80-87. doi: 10.1016/j.gene.2019.01.034. Epub 2019 Feb 2.
9
Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.miR-664的过表达通过靶向SOX7与骨肉瘤细胞迁移和侵袭能力增强相关。
Clin Exp Med. 2017 Feb;17(1):51-58. doi: 10.1007/s10238-015-0398-6. Epub 2015 Oct 29.
10
MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.miR-216b 通过靶向 Forkhead Box M1 抑制骨肉瘤细胞增殖、迁移和侵袭。
J Cell Biochem. 2019 Apr;120(4):5435-5443. doi: 10.1002/jcb.27822. Epub 2018 Oct 9.

引用本文的文献

1
Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63.人骨肉瘤细胞系MG-63中CD133阳性癌干细胞样细胞的微小RNA表达分析
PeerJ. 2021 Sep 3;9:e12115. doi: 10.7717/peerj.12115. eCollection 2021.
2
Clinical Significance and Biological Function of miR-1274a in Non-small Cell Lung Cancer.miR-1274a 在非小细胞肺癌中的临床意义和生物学功能。
Mol Biotechnol. 2022 Jan;64(1):9-16. doi: 10.1007/s12033-021-00385-w. Epub 2021 Aug 24.